Market revenue in 2023 | USD 28.5 million |
Market revenue in 2030 | USD 48.2 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Heart-lung machine |
Fastest growing segment | LVADs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | LVADs, Heart-lung Machine |
Key market players worldwide | Picard Medical, Carmat, BiVACOR, Abbott Laboratories, Johnson & Johnson, Symbion, LivaNova PLC, Getinge AB ADR, Terumo Corp, SynCardia Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial hearts market will help companies and investors design strategic landscapes.
Heart-lung machine was the largest segment with a revenue share of 76.49% in 2023. Horizon Databook has segmented the Australia artificial hearts market based on lvads, heart-lung machine covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia artificial hearts market , including forecasts for subscribers. This country databook contains high-level insights into Australia artificial hearts market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account